{"id":3154,"name":"Northpoint Ventures","slug":"northpoint-ventures","website":"https://northpoint.vc","hqGeo":"Minneapolis, MN","stageFocus":["Seed","Pre-Seed"],"sectorTags":["Other","SaaS","Consumer","Enterprise","Healthcare","AI / ML","Marketplace","Developer Tools"],"excludedSectors":["Entertainment"],"checkSizeMin":150000,"checkSizeMax":1200000,"thesisSummary":"Backing Midwest-based startups in B2B SaaS and E-commerce, with a deep preference for regional founders.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Fulfillly","companyUrl":null,"stage":null,"sector":"E-commerce","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"64x Bio","companyUrl":null,"stage":"Early-stage / growth","sector":"Gene therapy / Biomanufacturing","investmentYear":null,"description":"Engineering cell lines to address production/manufacturing bottlenecks in gene therapy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"908 Devices","companyUrl":null,"stage":"Commercial / Growth stage","sector":"Analytical instruments / Diagnostics / Tools","investmentYear":null,"description":"Makes handheld & desktop mass spectrometry devices to enable lab analyses anywhere","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ansa Biotechnologies","companyUrl":null,"stage":"Early / startup / pre-commercial","sector":"Synthetic biology / DNA synthesis","investmentYear":null,"description":"Building next-generation enzyme-based DNA synthesis to accelerate synthetic biology","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aro Biotherapeutics","companyUrl":null,"stage":"Preclinical / early-stage","sector":"Therapeutics / RNA / Delivery","investmentYear":null,"description":"Advances in protein engineering, nucleic acids, disease gene biology to achieve cell-specific oligonucleotide delivery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CAMP4 Therapeutics","companyUrl":null,"stage":"Preclinical","sector":"Gene regulation / Therapeutics","investmentYear":null,"description":"Preclinical biotech company pioneering upregulation (via an RNA class “regRNA”) to restore healthy gene expression","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Candel Therapeutics","companyUrl":null,"stage":"Late clinical stage","sector":"Oncology / Viral therapies","investmentYear":null,"description":"Developing oncolytic viral immunotherapies for cancers with high unmet need (e.g. Glioblastoma, prostate)","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ChromaCode","companyUrl":null,"stage":"Growth / scaling lab technology","sector":"Diagnostics / Lab tools","investmentYear":null,"description":"Enabling labs to process more samples per equipment/time without reducing accuracy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Code Bio","companyUrl":null,"stage":"Early / preclinical","sector":"Biologics / Therapeutics","investmentYear":null,"description":"Targeted, non-viral medicines for serious and life-threatening diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Culture Biosciences","companyUrl":null,"stage":"Tools / scaling stage","sector":"Bio-tools / Biotech platform","investmentYear":null,"description":"High-throughput bioreactor cloud lab to help scientists accelerate bioprocess development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Curie.Bio","companyUrl":null,"stage":"Seed / very early-stage","sector":"Drug discovery / Venture builder / Biotech startup studio","investmentYear":null,"description":"Helps founders launch therapeutics companies; acting as drug discovery copilot and seed investor","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Current Health","companyUrl":null,"stage":"Commercial / growth stage","sector":"Digital health / Remote monitoring","investmentYear":null,"description":"Enterprise remote-care management platform enabling early, preventive care at home","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Deep Lens","companyUrl":null,"stage":"Early / scaling","sector":"Clinical trial matching / Oncology tools","investmentYear":null,"description":"Helps care teams find clinical trials for patients at time of diagnosis","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Delfi Diagnostics","companyUrl":null,"stage":"Clinical / growth stage","sector":"Cancer diagnostics","investmentYear":null,"description":"Detects cancer earlier; enabling informed treatment decisions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"DICE Therapeutics","companyUrl":null,"stage":"Preclinical / early clinical","sector":"Therapeutics / Small molecule / Biologics alternative","investmentYear":null,"description":"Creating oral medicines with efficacy of biologics, for autoimmune disease sufferers","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"DNAnexus","companyUrl":null,"stage":"Growth / commercial","sector":"Bioinformatics / Cloud platform","investmentYear":null,"description":"Secure cloud platform and global network for scientific collaboration in genomics and precision medicine","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Eleanor Health","companyUrl":null,"stage":"Service / growth stage","sector":"Behavioral health / Healthcare delivery","investmentYear":null,"description":"Evidence-based, whole-person care model for mental health & substance use disorder services","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Elephas","companyUrl":null,"stage":"Early / commercializing","sector":"Oncology diagnostics / Imaging tools","investmentYear":null,"description":"Live tumor imaging company developing diagnostics to predict treatment outcomes & accelerate drug development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Emulate","companyUrl":null,"stage":"Growth / commercial","sector":"Bio-tools / Translational biology","investmentYear":null,"description":"Innovating organ-on-a-chip technology; simulating human responses to medicines, chemicals, foods","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Encodia","companyUrl":null,"stage":"Early-growth / tools","sector":"Proteomics / Research tools","investmentYear":null,"description":"Enables researchers to probe the proteome at greater scale and resolution than previously possible","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"EnPlusOne Biosciences","companyUrl":null,"stage":"Early / growth","sector":"RNA therapeutics / Biomanufacturing","investmentYear":null,"description":"Manufactures the RNA medicines of the future","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Faro Health","companyUrl":null,"stage":"Early stage","sector":"Clinical trial software / CRO-adjacent tech","investmentYear":null,"description":"Simplifies design & authoring of complex clinical trials using smart digital protocols","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"General Inception","companyUrl":null,"stage":"Seed / early stage","sector":"Startup builder / Incubator in biotech","investmentYear":null,"description":"Partners with inventors to translate innovations from inception to market","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Hawthorne Health","companyUrl":null,"stage":"Early / scaling","sector":"Decentralized trials / Participation models","investmentYear":null,"description":"Aimed at making clinical trials accessible & convenient for everyone","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Incendia Therapeutics","companyUrl":null,"stage":"Early / preclinical","sector":"Oncology / Immunology / Tumor microenvironment","investmentYear":null,"description":"Reimagining tumor microenvironment by creating anti-cancer therapies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Inflammatix","companyUrl":null,"stage":"Early / growth","sector":"Diagnostics / Immune profiling","investmentYear":null,"description":"Develops rapid immune system read-outs (e.g., for sepsis) to better characterize disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Intabio","companyUrl":null,"stage":"Early / commercializing","sector":"Bioproduction QC / Tools","investmentYear":null,"description":"Provides drug producers with rapid system to confirm quality standards in batch production","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Isolation Bio","companyUrl":null,"stage":"Early / tool / research stage","sector":"Microbiome research / Biotech","investmentYear":null,"description":"Enables access to living microbiome at unprecedented scale for deeper insights","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Isolere Bio","companyUrl":null,"stage":"Early / manufacturing stage","sector":"Downstream purification / Bioprocessing","investmentYear":null,"description":"Simplifies purification of biotherapeutics to improve global access","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kytopen","companyUrl":null,"stage":"Early / growth","sector":"Cell therapy manufacturing / Non-viral methods","investmentYear":null,"description":"Enables non-viral manufacturing of cell therapies in a scalable process","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Kyverna","companyUrl":null,"stage":"Clinical stage","sector":"Cell therapy / Therapeutics","investmentYear":null,"description":"Clinical-stage cell therapy company working on curative therapies for inflammatory & autoimmune diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MDSS (Merck Digital Sciences Studio)","companyUrl":null,"stage":"Early stage","sector":"AI tools / Drug development platform","investmentYear":null,"description":"Supports early-stage biomedical startups accelerating adoption of AI/ML tools for drug/biomarker discovery, clinical development, and infrastructure","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mestag Therapeutics","companyUrl":null,"stage":"Preclinical / early stage","sector":"Therapeutics / Fibrosis / Immunology","investmentYear":null,"description":"Targets activated fibroblast populations to influence immune system & create novel medicines","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Molecule","companyUrl":null,"stage":"Early / platform stage","sector":"Biotech marketplace / Funding platform","investmentYear":null,"description":"A marketplace + ecosystem leveraging Web3 to increase access to funding & commercialization for biotech research","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NanoView Biosciences","companyUrl":null,"stage":"Early / commercializing research tools","sector":"Diagnostics / Biomarkers / Exosomes","investmentYear":null,"description":"Characterizes exosomes (cell-cell communication vesicles) directly from sample without purification","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Octave Bioscience","companyUrl":null,"stage":"Growth stage","sector":"Digital health / Neurology care platform","investmentYear":null,"description":"Integrated care management platform for multiple sclerosis and other neurodegenerative disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"OMass Therapeutics","companyUrl":null,"stage":"Early discovery stage","sector":"Small molecules / Discovery platform","investmentYear":null,"description":"Combines mass spectrometry, biochemistry & custom chemistry to discover therapeutics for immunological & rare diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Opna Bio","companyUrl":null,"stage":"Clinical stage","sector":"Oncology therapeutics","investmentYear":null,"description":"Clinical-stage oncology company discovering novel therapies targeting multiple cancer drivers","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"OPT Industries","companyUrl":null,"stage":"Early stage / applied tech","sector":"Materials science / Manufacturing technology","investmentYear":null,"description":"Combines computational design, automation engineering, & material science to algorithmically design superior materials","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ori Biotech","companyUrl":null,"stage":"Early / growth manufacturing stage","sector":"Cell & gene therapy manufacturing / Automation","investmentYear":null,"description":"Automates and scales cell & gene therapy manufacturing to reduce cost & increase access","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Outcomes4Me","companyUrl":null,"stage":"Growth / deployed stage","sector":"Digital health / Oncology decision support","investmentYear":null,"description":"AI-powered platform integrating oncology patient health records + genomic sequencing to generate patient-specific treatment plans in real time","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PGDx (Personal Genome Diagnostics)","companyUrl":null,"stage":"Commercial / growth stage","sector":"Genomics / Cancer diagnostics","investmentYear":null,"description":"Advanced cancer genome analysis to help clinicians & researchers pick treatments sooner","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PhenomeX","companyUrl":null,"stage":"Early / research tools stage","sector":"Functional cell biology / Single cell tech","investmentYear":null,"description":"Empowers scientists to leverage single-cell functionality — functional cell biology advancing human health","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"QbDVision","companyUrl":null,"stage":"Early / platform‐commercializing stage","sector":"Biopharma manufacturing software / Platform","investmentYear":null,"description":"Digitizing biopharma manufacturing through cloud-based workflow & knowledge management","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Refeyn","companyUrl":null,"stage":"Early / commercializing tools","sector":"Single molecule detection / Analytical tools","investmentYear":null,"description":"Research tools company; finds & characterizes single molecules in ~1 minute to accelerate new drug discovery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Saama Technologies","companyUrl":null,"stage":"Growth / enterprise stage","sector":"Clinical analytics / AI in life sciences","investmentYear":null,"description":"AI clinical analytics platform enhancing safety & speed in clinical development & regulatory programs","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Scipher Medicine","companyUrl":null,"stage":"Early-growth / clinical use","sector":"Precision diagnostics / Molecular medicine","investmentYear":null,"description":"Diagnostic platform analyzing molecular data to ensure optimal therapy for individual patients","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Scitara","companyUrl":null,"stage":"Early / platform stage","sector":"Lab informatics / Data infrastructure","investmentYear":null,"description":"Provides lab-specific cloud software for lab data connectivity, tools & infrastructure","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Selux Diagnostics","companyUrl":null,"stage":"Early / clinical validation stage","sector":"Diagnostics / Infectious disease","investmentYear":null,"description":"Rapid antibiotic susceptibility testing, a critical need in infectious disease","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Sherlock Biosciences","companyUrl":null,"stage":"Growth stage","sector":"Diagnostics / Genetics / Point-of-care","investmentYear":null,"description":"Developing molecular diagnostics platform for simple, instrument-free tests; used in multiple diseases and non-clinical & clinical settings","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Teckro","companyUrl":null,"stage":"Growth / scale stage","sector":"Clinical trial technology / SaaS","investmentYear":null,"description":"Modernizing clinical trials; simplifying and making them more accessible, transparent","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Telesis","companyUrl":null,"stage":"Early stage","sector":"Genetic tools / Synthetic biology components","investmentYear":null,"description":"Bridges digital & biological worlds; creates precise genetic components needed for disease understanding & therapeutic development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Totus Medicines","companyUrl":null,"stage":"Discovery / early clinical","sector":"Therapeutics / Small molecule drug discovery","investmentYear":null,"description":"Invents covalent small-molecule medicines with potential for improved safety & efficacy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Transition Bio","companyUrl":null,"stage":"Early / discovery stage","sector":"Drug discovery platform / Novel biology / Technology","investmentYear":null,"description":"Microfluidics + ML-driven company exploring biomolecular condensates to revolutionize drug discovery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Triumvira","companyUrl":null,"stage":"Clinical stage","sector":"Cell therapy / Oncology","investmentYear":null,"description":"Clinical-stage oncology cell therapy company developing both autologous & allogeneic therapies with enhanced safety & efficacy","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ultivue","companyUrl":null,"stage":"Growth / commercial","sector":"Biomarker / Diagnostics / Research tools","investmentYear":null,"description":"Immunohistochemistry platform used in cancer research to provide comprehensive biomarker info; helps advance drugs into and through trials","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vestaron","companyUrl":null,"stage":"Early stage / applied biotech","sector":"Agriculture biotech / Sustainable chemicals","investmentYear":null,"description":"Developing environmentally-friendly peptide-based biopesticides for crop protection","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"VieCure","companyUrl":null,"stage":"Growth / deployed clinical stage","sector":"Personalized medicine / Oncology / AI","investmentYear":null,"description":"AI-powered platform integrating oncology health records + genomics to generate patient-specific, actionable treatment plans in real-time","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vigil Neuroscience","companyUrl":null,"stage":"Early clinical / discovery pipeline","sector":"Neurology / Neurodegeneration / Therapeutics","investmentYear":null,"description":"First microglia-focused neurodegenerative disease company; aims to restore microglia function (brain immune support)","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":4,"partners":[{"id":20698,"name":"Sharon Kedar, CFA","title":"Co-Founder, Partner","seniority":null,"focusTags":["Science-driven innovation","Venture capital","Diagnostics/life sciences"],"linkedinUrl":"https://www.linkedin.com/in/sharon-kedar-cfa/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":20699,"name":"Andrea Jackson","title":"Partner","seniority":null,"focusTags":["Science & technology VC investments","Life sciences","Digital health"],"linkedinUrl":"https://www.linkedin.com/in/andrea-jackson-npv/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":2902,"name":"Sarah Levin","title":"GP","seniority":null,"focusTags":["E-commerce","SMB Enablement"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":20697,"name":"Michael P. Rubin, M.D., Ph.D., CFA","title":"Founder & CEO","seniority":null,"focusTags":["Science-driven technology","Life sciences","Translational research"],"linkedinUrl":"https://www.linkedin.com/in/michael-prubin/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":4965,"name":"Perennial Edge Ventures","slug":"perennial-edge-ventures","logoUrl":null,"website":"https://perennialedge.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","SaaS"],"hqGeo":"Boston, MA"},{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":547,"name":"Cocoa VC","slug":"cocoa-vc","logoUrl":null,"website":"https://www.cocoa.vc/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","SaaS","Other"],"hqGeo":"San Francisco, CA"},{"id":6492,"name":"Breed Reply","slug":"breed-reply","logoUrl":null,"website":"https://www.reply.com/","stageFocus":[],"sectorTags":["Healthcare","Security"],"hqGeo":null},{"id":4903,"name":"Latency Ventures","slug":"latency-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","Enterprise","SaaS"],"hqGeo":"Denver, CO"},{"id":10061,"name":"dWeb Ventures","slug":"dweb-ventures","logoUrl":null,"website":"https://webventures.io/","stageFocus":["Seed"],"sectorTags":["Other","Developer Tools"],"hqGeo":"San Francisco, CA"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"saas","displayName":"SaaS Investors","pageType":"industry"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"},{"slug":"marketplace","displayName":"Marketplace Investors","pageType":"industry"},{"slug":"consumer","displayName":"Consumer Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-05-11T23:53:37.277Z"}